3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Leukemia, Myeloid, Acute
17
Leukemia
15
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Myelodysplastic Syndromes
12
Lymphoma
11
Multiple Myeloma
9
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
8
Lymphoma, Non-Hodgkin
7
Leukemia, Lymphocytic, Chronic, B-Cell
6
Hematologic Neoplasms
5
Hodgkin Disease
4
Sarcoma, Ewing
3
Rhabdomyosarcoma
3
Neuroblastoma
3
Neoplasms, Plasma Cell
3
Lymphoma, Follicular
3
Graft vs Host Disease
3
Burkitt Lymphoma
3
Brain Neoplasms
3
Wilms Tumor
2
Waldenstrom Macroglobulinemia
2
Testicular Neoplasms
2
Sarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neoplasms
2
Myeloproliferative Disorders
2
Medulloblastoma
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Myeloid
2
Interventions
Methotrexate
21
Ifosfamide
21
Cyclophosphamide
19
Doxorubicin
17
Cisplatin
14
Filgrastim
13
Gemcitabine
12
Etoposide
11
Leucovorin
9
apatinib
8
fludarabine
7
glucarpidase
6
Vincristine
6
Temozolomide
6
Radiotherapy
6
Nivolumab
6
Neoadjuvant Therapy
6
Drug Therapy
6
Carboplatin
6
regorafenib
5
cabozantinib
5
Zoledronic Acid
5
Topotecan
5
Mesna
5
Irinotecan
5
Granulocyte Colony-Stimulating Factor
5
Docetaxel
5
pembrolizumab
4
pegfilgrastim
4
camrelizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Osteosarcoma
×
Bone Marrow Transplantation
×
Clear all
NCT02100891
2025-03-19
STIR
Medical College of Wisconsin
Phase 2
Terminated
15 enrolled
11 charts